Literature DB >> 24374826

Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3.

Spencer Slavin1, Chiuan-Ren Yeh1, Jun Da2, Shengqiang Yu1, Hiroshi Miyamoto1, Edward M Messing1, Elizabeth Guancial3, Shuyuan Yeh4.   

Abstract

The prostate cancer (PCa) microenvironment contains active stromal cells known as cancer-associated fibroblasts (CAF) that may play important roles in influencing tumor progression. Here we studied the role of CAF estrogen receptor alpha (ERα) and found that it could protect against PCa invasion. Immunohistochemistry on prostatectomy specimens showed that PCa patients with ERα-positive stroma had a significantly lower risk for biochemical recurrence. In vitro invasion assays further confirmed that the stromal ERα was able to reduce PCa cell invasion. Dissection of the molecular mechanism revealed that the CAF ERα could function through a CAF-epithelial interaction via selectively upregulating thrombospondin 2 (Thbs2) and downregulating matrix metalloproteinase 3 (MMP3) at the protein and messenger RNA levels. Chromatin immunoprecipitation assays further showed that ERα could bind to an estrogen response element on the promoter of Thbs2. Importantly, knockdown of Thbs2 led to increased MMP3 expression and interruption of the ERα mediated invasion suppression, providing further evidence of an ERα-Thbs2-MMP3 axis in CAF. In vivo studies using athymic nude mice injected with CWR22Rv1 (22Rv1) PCa epithelial cells and CAF cells ± ERα also confirmed that mice coimplanted with PCa cells and CAF ERα+ cells had less tumor foci in the pelvic lymph nodes, less metastases, and tumors showed less angiogenesis, MMP3, and MMP9 (an MMP3 downstream target) positive staining. Together, these data suggest that CAF ERα could play protective roles in suppressing PCa metastasis. Our results may lead to developing new and alternative therapeutic approaches to battle PCa via controlling ERα signaling in CAF.
© The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24374826      PMCID: PMC4043239          DOI: 10.1093/carcin/bgt488

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  51 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

2.  A local paracrine and endocrine network involving TGFβ, Cox-2, ROS, and estrogen receptor β influences reactive stromal cell regulation of prostate cancer cell motility.

Authors:  Melanie J Grubisha; M E Cifuentes; Stephen R Hammes; Donald B Defranco
Journal:  Mol Endocrinol       Date:  2012-05-16

3.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Authors:  M Streit; L Riccardi; P Velasco; L F Brown; T Hawighorst; P Bornstein; M Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age.

Authors:  D L Hemsell; J M Grodin; P F Brenner; P K Siiteri; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

5.  Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice.

Authors:  Ming Chen; Chiuan-Ren Yeh; Chih-Rong Shyr; Hsiu-Hsia Lin; Jun Da; Shuyuan Yeh
Journal:  Asian J Androl       Date:  2012-05-21       Impact factor: 3.285

6.  Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.

Authors:  Lin Yu; Chun-Yu Wang; Jiandang Shi; Lin Miao; Xiaoling Du; Doris Mayer; Ju Zhang
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 8.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

9.  CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.

Authors:  Ming Chen; Jing Ni; Hong-Chiang Chang; Chen-Yong Lin; Mesut Muyan; Shuyuan Yeh
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  30 in total

1.  Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.

Authors:  Chiuan-Ren Yeh; Iawen Hsu; Wenbin Song; Hongchiang Chang; Hiroshi Miyamoto; Guang-Qian Xiao; Lei Li; Shuyuan Yeh
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 2.  Estrogen receptors in prostate development and cancer.

Authors:  Chiuan-Ren Yeh; Jun Da; Wenbin Song; Anees Fazili; Shuyuan Yeh
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

3.  Sex-specific multi-level 3D genome dynamics in the mouse brain.

Authors:  Devin Rocks; Mamta Shukla; Laila Ouldibbat; Silvia C Finnemann; Achyuth Kalluchi; M Jordan Rowley; Marija Kundakovic
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

Review 4.  Sexual dimorphism in cancer.

Authors:  Andrea Clocchiatti; Elisa Cora; Yosra Zhang; G Paolo Dotto
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

5.  Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts.

Authors:  Ridwana Chowdhury; Jason P Webber; Mark Gurney; Malcolm D Mason; Zsuzsanna Tabi; Aled Clayton
Journal:  Oncotarget       Date:  2015-01-20

6.  BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts.

Authors:  Simeng Wen; Yuanjie Niu; Shuyuan Yeh; Chawnshang Chang
Journal:  Int J Oncol       Date:  2015-06-22       Impact factor: 5.650

7.  Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals.

Authors:  Wenbin Song; Chiuan-Ren Yeh; Dalin He; Yong Wang; Hongjun Xie; See-Tong Pang; Luke Sien-Shih Chang; Lei Li; Shuyuan Yeh
Journal:  Oncotarget       Date:  2015-08-07

Review 8.  Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.

Authors:  Chung Lee; Zhenyu Jia; Farah Rahmatpanah; Qiang Zhang; Xiaolin Zi; Michael McClelland; Dan Mercola
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

Review 9.  Oestrogens and oestrogen receptors in prostate cancer.

Authors:  Karolina Kowalska; Agnieszka Wanda Piastowska-Ciesielska
Journal:  Springerplus       Date:  2016-04-26

10.  Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.

Authors:  Chiuan-Ren Yeh; Spencer Slavin; Jun Da; Iawen Hsu; Jie Luo; Guang-Qian Xiao; Jie Ding; Fu-Ju Chou; Shuyuan Yeh
Journal:  Mol Cancer       Date:  2016-01-20       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.